Article
Treatment of brain metastases in the modern genomic era.
Pharmacology & therapeutics - 1 Feb 2017
Dagogo-Jack Ibiayi, Gill Corey M, Cahill Daniel P, Santagata Sandro, Brastianos Priscilla K
Abstract excerpt
Development of brain metastasis (BM) portends a dismal prognosis for patients with cancer. Melanomas and carcinomas of the lung, breast, and kidney are the most common malignancies to metastasize to the brain. Recent advances in molecular genetics have enabled the identification of actionable, clinically relevant genetic alterations within primary tumors and their corresponding metastases. Adoption of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
